Q4 2019 Holdings
Filed 2020-02-13 | 72 holdings | $566.3M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2023-11-08) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Spdr S&P 500 ETF TR(SPY)PutA | TR UNIT | 78462F103 | $51.5M | 160,000 | 9.1% |
| Glaxosmithkline PLCA | SPONSORED ADR | 37733W105 | $48.6M | 1,023,085 | 8.6% |
| Ensign Group Inc(ENSG)A | COM | 29358P101 | $30.7M | 676,058 | 5.4% |
| Danaher Corporation(DHR)A | COM | 235851102 | $30.3M | 197,107 | 5.3% |
| Ascendis Pharma A S(ASND)A | SPONSORED ADR | 04351P101 | $28.2M | 202,894 | 5.0% |
| Zogenix IncA | COM NEW | 98978L204 | $25.8M | 495,645 | 4.6% |
| Sanofi(SNY)A | SPONSORED ADR | 80105N105 | $22.2M | 441,661 | 3.9% |
| Amarin Corp PLCCallA | SPONS ADR NEW | 023111206 | $21.3M | 994,200 | 3.8% |
| Chemocentryx Inc(CCXIEUR)A | COM | 16383L106 | $20.3M | 513,189 | 3.6% |
| Amarin Corp PLCA | SPONS ADR NEW | 023111206 | $19.6M | 915,590 | 3.5% |
| Audentes Therapeutics Inc(BOLDEUR)A | COM | 05070R104 | $18.3M | 305,726 | 3.2% |
| Biocryst Pharmaceuticals(BCRX)A | COM | 09058V103 | $16.9M | 4,904,460 | 3.0% |
| Vertex Pharmaceuticals Inc(VRTX)A | COM | 92532F100 | $16.0M | 73,009 | 2.8% |
| Envista Hldgs Corp(NVST)A | COM | 29415F104 | $15.0M | 506,678 | 2.7% |
| Pennant Group Inc(PNTG)A | COM | 70805E109 | $12.3M | 371,193 | 2.2% |
| Medicines CoA | COM | 584688105 | $9.7M | 114,358 | 1.7% |
| Sarepta Therapeutics Inc(SRPT)A | COM | 803607100 | $9.7M | 75,000 | 1.7% |
| Apellis Pharmaceuticals Inc(APLS)A | COM | 03753U106 | $9.5M | 310,409 | 1.7% |
| TG Therapeutics Inc(TGTX)A | COM | 88322Q108 | $8.6M | 776,323 | 1.5% |
| Deciphera Pharmaceuticals in(DCPHEUR)A | COM | 24344T101 | $8.0M | 128,748 | 1.4% |
| Model N Inc(MODNEUR)A | COM | 607525102 | $7.3M | 207,615 | 1.3% |
| Fate Therapeutics Inc(FATE)A | COM | 31189P102 | $7.1M | 360,656 | 1.2% |
| Astrazeneca PLC(AZN)A | SPONSORED ADR | 046353108 | $7.0M | 140,562 | 1.2% |
| Bluebird BIO IncA | COM | 09609G100 | $6.4M | 73,400 | 1.1% |
| Radius Health IncA | COM NEW | 750469207 | $6.4M | 318,811 | 1.1% |
| Argenx SE(ARGX)A | SPONSORED ADR | 04016X101 | $6.0M | 37,204 | 1.1% |
| Illumina Inc(ILMN)A | COM | 452327109 | $5.9M | 17,750 | 1.0% |
| Oxford Immunotec Global PLCA | ORD SHS | G6855A103 | $5.8M | 349,823 | 1.0% |
| R1 RCM IncA | COM | 749397105 | $5.4M | 416,726 | 1.0% |
| Natera Inc(NTRA)A | COM | 632307104 | $5.3M | 157,081 | 0.9% |
| Kadmon Hldgs Inc(KDMN)A | COM | 48283N106 | $5.2M | 1,141,939 | 0.9% |
| Guardant Health Inc(GH)A | COM | 40131M109 | $5.1M | 64,720 | 0.9% |
| Qiagen NV(QGEN)A | SHS NEW | N72482123 | $4.6M | 137,000 | 0.8% |
| Ehealth Inc(EHTH)A | COM | 28238P109 | $3.0M | 31,653 | 0.5% |
| Omega Healthcare Invs Inc(OHI)A | COM | 681936100 | $3.0M | 71,500 | 0.5% |
| Anthem Inc(ELV)A | COM | 036752103 | $3.0M | 10,000 | 0.5% |
| Agile Therapeutics Inc(AGRXUSD)A | COM | 00847L100 | $2.8M | 1,136,006 | 0.5% |
| Xenon Pharmaceuticals Inc(XENE)A | COM | 98420N105 | $2.8M | 215,609 | 0.5% |
| LTC Pptys Inc(LTC)A | COM | 502175102 | $2.7M | 59,327 | 0.5% |
| Dexcom Inc(DXCM)A | COM | 252131107 | $2.6M | 12,050 | 0.5% |
| Centene Corp del(CNC)A | COM | 15135B101 | $2.5M | 40,000 | 0.4% |
| IGM Biosciences Inc(1K0)A | COM | 449585108 | $2.5M | 64,600 | 0.4% |
| Affimed N VA | COM | N01045108 | $2.4M | 857,771 | 0.4% |
| Collegium Pharmaceutical Inc(COLL)A | COM | 19459J104 | $2.3M | 111,361 | 0.4% |
| Caretrust REIT Inc(CTRE)A | COM | 14174T107 | $2.2M | 107,464 | 0.4% |
| Biodelivery Sciences Intl in(BDSIUSD)A | COM | 09060J106 | $2.1M | 335,485 | 0.4% |
| Otonomy IncA | COM | 68906L105 | $2.1M | 550,665 | 0.4% |
| Aquestive Therapeutics Inc(AQST) | COM | 03843E104 | $2.0M | 350,000 | 0.4% |
| Heska Corp(HSKAEUR)A | COM RESTRC NEW | 42805E306 | $2.0M | 20,771 | 0.4% |
| Albireo Pharma Inc(BDQM)A | COM | 01345P106 | $2.0M | 78,029 | 0.4% |